These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1492 related articles for article (PubMed ID: 33295957)

  • 1. Mucocutaneous Manifestations of Multisystem Inflammatory Syndrome in Children During the COVID-19 Pandemic.
    Young TK; Shaw KS; Shah JK; Noor A; Alperin RA; Ratner AJ; Orlow SJ; Betensky RA; Shust GF; Kahn PJ; Oza VS
    JAMA Dermatol; 2021 Feb; 157(2):207-212. PubMed ID: 33295957
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mucocutaneous disease and related clinical characteristics in hospitalized children and adolescents with COVID-19 and multisystem inflammatory syndrome in children.
    Rekhtman S; Tannenbaum R; Strunk A; Birabaharan M; Wright S; Garg A
    J Am Acad Dermatol; 2021 Feb; 84(2):408-414. PubMed ID: 33323343
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical Characteristics of 58 Children With a Pediatric Inflammatory Multisystem Syndrome Temporally Associated With SARS-CoV-2.
    Whittaker E; Bamford A; Kenny J; Kaforou M; Jones CE; Shah P; Ramnarayan P; Fraisse A; Miller O; Davies P; Kucera F; Brierley J; McDougall M; Carter M; Tremoulet A; Shimizu C; Herberg J; Burns JC; Lyall H; Levin M;
    JAMA; 2020 Jul; 324(3):259-269. PubMed ID: 32511692
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dermatologic manifestations of multisystem inflammatory syndrome in children during the COVID-19 pandemic.
    Baykal Selçuk L; Ferhatosmanoğlu A; Gayretli Aydın ZG; Aksu Arıca D; Yeşilbaş O
    An Bras Dermatol; 2023; 98(2):168-175. PubMed ID: 36473757
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multisystem Inflammatory Syndrome in Children in New York State.
    Dufort EM; Koumans EH; Chow EJ; Rosenthal EM; Muse A; Rowlands J; Barranco MA; Maxted AM; Rosenberg ES; Easton D; Udo T; Kumar J; Pulver W; Smith L; Hutton B; Blog D; Zucker H;
    N Engl J Med; 2020 Jul; 383(4):347-358. PubMed ID: 32598830
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mucocutaneous manifestations in children hospitalized with COVID-19.
    Andina-Martinez D; Nieto-Moro M; Alonso-Cadenas JA; Añon-Hidalgo J; Hernandez-Martin A; Perez-Suarez E; Colmenero-Blanco I; Iglesias-Bouza MI; Cano-Fernandez J; Mateos-Mayo A; Torrelo A
    J Am Acad Dermatol; 2021 Jul; 85(1):88-94. PubMed ID: 33819537
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical characteristics of children and young people admitted to hospital with covid-19 in United Kingdom: prospective multicentre observational cohort study.
    Swann OV; Holden KA; Turtle L; Pollock L; Fairfield CJ; Drake TM; Seth S; Egan C; Hardwick HE; Halpin S; Girvan M; Donohue C; Pritchard M; Patel LB; Ladhani S; Sigfrid L; Sinha IP; Olliaro PL; Nguyen-Van-Tam JS; Horby PW; Merson L; Carson G; Dunning J; Openshaw PJM; Baillie JK; Harrison EM; Docherty AB; Semple MG;
    BMJ; 2020 Aug; 370():m3249. PubMed ID: 32960186
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factors linked to severe outcomes in multisystem inflammatory syndrome in children (MIS-C) in the USA: a retrospective surveillance study.
    Abrams JY; Oster ME; Godfred-Cato SE; Bryant B; Datta SD; Campbell AP; Leung JW; Tsang CA; Pierce TJ; Kennedy JL; Hammett TA; Belay ED
    Lancet Child Adolesc Health; 2021 May; 5(5):323-331. PubMed ID: 33711293
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characteristics and Outcomes of US Children and Adolescents With Multisystem Inflammatory Syndrome in Children (MIS-C) Compared With Severe Acute COVID-19.
    Feldstein LR; Tenforde MW; Friedman KG; Newhams M; Rose EB; Dapul H; Soma VL; Maddux AB; Mourani PM; Bowens C; Maamari M; Hall MW; Riggs BJ; Giuliano JS; Singh AR; Li S; Kong M; Schuster JE; McLaughlin GE; Schwartz SP; Walker TC; Loftis LL; Hobbs CV; Halasa NB; Doymaz S; Babbitt CJ; Hume JR; Gertz SJ; Irby K; Clouser KN; Cvijanovich NZ; Bradford TT; Smith LS; Heidemann SM; Zackai SP; Wellnitz K; Nofziger RA; Horwitz SM; Carroll RW; Rowan CM; Tarquinio KM; Mack EH; Fitzgerald JC; Coates BM; Jackson AM; Young CC; Son MBF; Patel MM; Newburger JW; Randolph AG;
    JAMA; 2021 Mar; 325(11):1074-1087. PubMed ID: 33625505
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multisystem inflammatory syndrome associated with SARS-CoV-2 infection in 45 children: a first report from Iran.
    Mamishi S; Movahedi Z; Mohammadi M; Ziaee V; Khodabandeh M; Abdolsalehi MR; Navaeian A; Heydari H; Mahmoudi S; Pourakbari B
    Epidemiol Infect; 2020 Aug; 148():e196. PubMed ID: 32854812
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trends in Geographic and Temporal Distribution of US Children With Multisystem Inflammatory Syndrome During the COVID-19 Pandemic.
    Belay ED; Abrams J; Oster ME; Giovanni J; Pierce T; Meng L; Prezzato E; Balachandran N; Openshaw JJ; Rosen HE; Kim M; Richardson G; Hand J; Tobin-D'Angelo M; Wilson S; Hartley A; Jones C; Kolsin J; Mohamed H; Colles Z; Hammett T; Patel P; Stierman B; Campbell AP; Godfred-Cato S
    JAMA Pediatr; 2021 Aug; 175(8):837-845. PubMed ID: 33821923
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative SARS-CoV-2 Serology in Children With Multisystem Inflammatory Syndrome (MIS-C).
    Rostad CA; Chahroudi A; Mantus G; Lapp SA; Teherani M; Macoy L; Tarquinio KM; Basu RK; Kao C; Linam WM; Zimmerman MG; Shi PY; Menachery VD; Oster ME; Edupuganti S; Anderson EJ; Suthar MS; Wrammert J; Jaggi P
    Pediatrics; 2020 Dec; 146(6):. PubMed ID: 32879033
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors Associated With Severe Gastrointestinal Diagnoses in Children With SARS-CoV-2 Infection or Multisystem Inflammatory Syndrome.
    Lo Vecchio A; Garazzino S; Smarrazzo A; Venturini E; Poeta M; Berlese P; Denina M; Meini A; Bosis S; Galli L; Cazzato S; Nicolini G; Vergine G; Giacchero R; Ballardini G; Dodi I; Salvini FM; Manzoni P; Ferrante G; Quadri V; Campana A; Badolato R; Villani A; Guarino A; Gattinara GC;
    JAMA Netw Open; 2021 Dec; 4(12):e2139974. PubMed ID: 34928354
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Severity of multisystem inflammatory syndrome in children (MIS-C) in patients with and without mucocutaneous findings.
    Rao M; Bond C; Haggstrom A; Bhumbra S
    Pediatr Dermatol; 2023 Mar; 40(2):294-300. PubMed ID: 36627110
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute Heart Failure in Multisystem Inflammatory Syndrome in Children in the Context of Global SARS-CoV-2 Pandemic.
    Belhadjer Z; Méot M; Bajolle F; Khraiche D; Legendre A; Abakka S; Auriau J; Grimaud M; Oualha M; Beghetti M; Wacker J; Ovaert C; Hascoet S; Selegny M; Malekzadeh-Milani S; Maltret A; Bosser G; Giroux N; Bonnemains L; Bordet J; Di Filippo S; Mauran P; Falcon-Eicher S; Thambo JB; Lefort B; Moceri P; Houyel L; Renolleau S; Bonnet D
    Circulation; 2020 Aug; 142(5):429-436. PubMed ID: 32418446
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Shock and Myocardial Injury in Children With Multisystem Inflammatory Syndrome Associated With SARS-CoV-2 Infection: What We Know. Case Series and Review of the Literature.
    Caro-Patón GL; de Azagra-Garde AM; García-Salido A; Cabrero-Hernández M; Tamariz A; Nieto-Moro M
    J Intensive Care Med; 2021 Apr; 36(4):392-403. PubMed ID: 33148089
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral manifestations of COVID-2019-related multisystem inflammatory syndrome in children: a review of 47 pediatric patients.
    Halepas S; Lee KC; Myers A; Yoon RK; Chung W; Peters SM
    J Am Dent Assoc; 2021 Mar; 152(3):202-208. PubMed ID: 33632409
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Severe manifestations of SARS-CoV-2 in children and adolescents: from COVID-19 pneumonia to multisystem inflammatory syndrome: a multicentre study in pediatric intensive care units in Spain.
    García-Salido A; de Carlos Vicente JC; Belda Hofheinz S; Balcells Ramírez J; Slöcker Barrio M; Leóz Gordillo I; Hernández Yuste A; Guitart Pardellans C; Cuervas-Mons Tejedor M; Huidobro Labarga B; Vázquez Martínez JL; Gutiérrez Jimeno M; Oulego-Erróz I; Trastoy Quintela J; Medina Monzón C; Medina Ramos L; Holanda Peña MS; Gil-Antón J; Sorribes Ortí C; Flores González JC; Hernández Palomo RM; Sánchez Ganfornina I; Fernández Romero E; García-Besteiro M; López-Herce Cid J; González Cortés R;
    Crit Care; 2020 Nov; 24(1):666. PubMed ID: 33243303
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in Distribution of Severe Neurologic Involvement in US Pediatric Inpatients With COVID-19 or Multisystem Inflammatory Syndrome in Children in 2021 vs 2020.
    LaRovere KL; Poussaint TY; Young CC; Newhams MM; Kucukak S; Irby K; Kong M; Schwartz SP; Walker TC; Bembea MM; Wellnitz K; Havlin KM; Cvijanovich NZ; Hall MW; Fitzgerald JC; Schuster JE; Hobbs CV; Halasa NB; Singh AR; Mack EH; Bradford TT; Gertz SJ; Schwarz AJ; Typpo KV; Loftis LL; Giuliano JS; Horwitz SM; Biagas KV; Clouser KN; Rowan CM; Maddux AB; Soma VL; Babbitt CJ; Aguiar CL; Kolmar AR; Heidemann SM; Harvey H; Zambrano LD; Campbell AP; Randolph AG;
    JAMA Neurol; 2023 Jan; 80(1):91-98. PubMed ID: 36342679
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multisystem Inflammatory Syndrome in Children (MIS-C) Associated with COVID-19: A Case Series Experience in a Tertiary Care Hospital of Southern Turkey.
    Tolunay O; Çelik Ü; Arslan İ; Orgun A; Demir H; Demir O; Dağdelen EÇ
    J Trop Pediatr; 2021 May; 67(2):. PubMed ID: 34028528
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 75.